Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
13 mg [14C]-A4250 capsule----3件: 93, 297, 338
2A4250----4件: 93, 296, 297, 338
3A4250-015----1件: 297
4Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
5Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
6CRC (A3384)----3件: 93, 297, 338
7Eicosapentaenoic acid1件: Icosapent1件: D08061 --6件: 49, 96, 97, 296, 297, 338
8LUM001----4件: 93, 94, 297, 338
9LUM001 (Maralixibat)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 297
10Magnesium1件: Magnesium---15件: 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298
11Magnesium gluconate1件: Magnesium gluconate1件: D04835 --2件: 296, 297
12Magnesium sulfate3件: Magnesium gluconate,
Magnesium sulfate,
Sulfate ion		2件: D01108 ,
D04835 		--3件: 11, 296, 297
13Maralixibat1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
14Maralixibat (formely SHP625 or LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
15MARALIXIBAT CHLORIDE2件: Chloride ion,
Maralixibat		1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
16Odevixibat1件: Odevixibat1件: D11716 1件: SLC10A2 💬1件: Bile secretion 💬3件: 296, 297, 338
17PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
18Questran1件: Cholestyramine---4件: 93, 254, 297, 338
19Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299
20TAK-625----2件: 297, 338